These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 10503245)

  • 1. "De novo" design of peptides with specific lipid-binding properties.
    Lins L; Charloteaux B; Heinen C; Thomas A; Brasseur R
    Biophys J; 2006 Jan; 90(2):470-9. PubMed ID: 16275638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of hydrophobic residues is crucial for the fusogenic properties of the Ebola virus GP2 fusion peptide.
    Adam B; Lins L; Stroobant V; Thomas A; Brasseur R
    J Virol; 2004 Feb; 78(4):2131-6. PubMed ID: 14747578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle-directed gene therapy: hijacking the fusogenic properties of muscle cells.
    Büning H; Morgan M; Schambach A
    Signal Transduct Target Ther; 2023 Sep; 8(1):340. PubMed ID: 37699901
    [No Abstract]   [Full Text] [Related]  

  • 4. Peptide-based delivery of therapeutics in cancer treatment.
    Samec T; Boulos J; Gilmore S; Hazelton A; Alexander-Bryant A
    Mater Today Bio; 2022 Mar; 14():100248. PubMed ID: 35434595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A theoretical investigation into the lipid interactions of m-calpain.
    Daman A; Harris F; Biswas S; Wallace J; Phoenix DA
    Mol Cell Biochem; 2001 Jul; 223(1-2):159-63. PubMed ID: 11681718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lecithin cholesterol acyltransferase.
    Jonas A
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):245-56. PubMed ID: 11111093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the hydrophobicity gradient of an amphipathic peptide to its mode of association with lipids.
    Pérez-Méndez O; Vanloo B; Decout A; Goethals M; Peelman F; Vandekerckhove J; Brasseur R; Rosseneu M
    Eur J Biochem; 1998 Sep; 256(3):570-9. PubMed ID: 9780233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional properties of the 154-171 wild-type and variant peptides of human lecithin-cholesterol acyltransferase.
    Peelman F; Goethals M; Vanloo B; Labeur C; Brasseur R; Vandekerckhove J; Rosseneu M
    Eur J Biochem; 1997 Nov; 249(3):708-15. PubMed ID: 9395317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C-terminal helix of human apolipoprotein AII promotes the fusion of unilamellar liposomes and displaces apolipoprotein AI from high-density lipoproteins.
    Lambert G; Decout A; Vanloo B; Rouy D; Duverger N; Kalopissis A; Vandekerckhove J; Chambaz J; Brasseur R; Rosseneu M
    Eur J Biochem; 1998 Apr; 253(1):328-38. PubMed ID: 9578492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion.
    Pillot T; Lins L; Goethals M; Vanloo B; Baert J; Vandekerckhove J; Rosseneu M; Brasseur R
    J Mol Biol; 1997 Dec; 274(3):381-93. PubMed ID: 9405147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of synthetic peptide analogs of the amphipathic helix. Effect of charge distribution, hydrophobicity, and secondary structure on lipid association and lecithin:cholesterol acyltransferase activation.
    Epand RM; Gawish A; Iqbal M; Gupta KB; Chen CH; Segrest JP; Anantharamaiah GM
    J Biol Chem; 1987 Jul; 262(19):9389-96. PubMed ID: 3597415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of the hydrophobicity gradient to the secondary structure and activity of fusogenic peptides.
    Decout A; Labeur C; Vanloo B; Goethals M; Vandekerckhove J; Brasseur R; Rosseneu M
    Mol Membr Biol; 1999; 16(3):237-46. PubMed ID: 10503245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parameters modulating the maximum insertion pressure of proteins and peptides in lipid monolayers.
    Calvez P; Bussières S; Eric Demers ; Salesse C
    Biochimie; 2009 Jun; 91(6):718-33. PubMed ID: 19345719
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.